News from INC Research, Y-Prime and Ariana – People on the move
Outsourcing-Pharma.com presents its weekly round-up of the latest chops and changes in the world of pharmaceuticals, including news from INC Research, Y-Prime and Ariana.
Archives for August 29, 2012
QPS buys JSW Life Sciences, boosts CNS
QPS has boosted its late phase offering after acquiring Austrian-based JSW Life Sciences.
Siegfried sees sales and earnings grow in H1
Siegfried says lower raw materials costs helped its API business grow in the first half of 2012 and set out plans to expand manufacturing operations in China.
CDSCO gives manufacturers three weeks to comply with PSUR reporting rules
Drugmakers and importers are not complying with safety reporting requirements according to the Indian Drugs Controller General (DCG), which has given the offending firms three weeks to comply.
Hospira buys Indian API plant to boost antibiotics biz
Hospira has bought Orchid Chemicals and Pharmaceutical’s active pharmaceutical ingredient (API) facility in Aurangabad, India, to support its expanding antibiotic business.
Emerging market regulatory staff should take test to level playing field, RAPS
Regulatory professionals working for contract research organisations (CROs) in emerging markets could benefit from taking a test to bring them up to par with those in developed countries, according to RAPS.
Mixed response to EC plan to extend Directive 2003/94/EC to APIs
The EC plan to extend drug GMP guidelines to APIs has met with a mixed response from industry groups, drugmakers and API manufacturers with some - like DSM and CEFIC – asking for clarification on the future of EudraLex Volume 4 Part II.